AMAG Pharmaceuticals Inc (USD)
AMAG
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range10.70 | 11.18
52-Wk Range6.81 | 18.39
Last Close10.71
Mkt Cap (m)363.24
Dividend yield-
ISINUS00163U1060
Volume160,386
Exchange VenueNAS

Company Profile

AMAG Pharmaceuticals Inc is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and to aid in the diagnosis of cancer.

Key Information
Price/Earning-
Price/Book0.76
Price/Sales1.12
P/CF-
Rev Growth (3 year avg)4.26
EPS Growth (3 year avg)-
Operating Margin % -13.53
Net Margin %-13.87
Return on Equity-8.56
Debt/Equity0.38

Legal Documents

Prospectus
en 08/05/2017
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)81124418532610474
Operating Income (m)-1281279944-64
Net Income (m)-1013633-2-199-66
Basic EPS-0.446.061.04-0.07-5.71-1.91
Avg. Diluted Shares Outstanding (m)222535343534
Balance Sheet
USD201320142015201620172018
Current Assets (m)244274607719482525
Non Current Assets (m)211,1151,8811,7601,371650
Total Assets (m)2651,3892,4872,4781,8531,175
Current Liabilities (m)33166246313278165
Total Liabilities (m)------
Total Equity (m)172460932934790747
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-7119624610861
Capital Expenditure (m)-2-1-5-65-3
Figures are quoted in USD unless stated otherwise
0.33 (3.08%)
$
11.04
Last Price